학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 221건 | 목록 1~10
Academic Journal
Serra-Bardenys G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Institut Bonanova FP Sanitaria, Consorci Mar Parc de Salut de Barcelona, Spain.; Blanco E; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Escudero-Iriarte C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Serra-Camprubí Q; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Querol J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Pascual-Reguant L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Morancho B; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Escorihuela M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Tissera NS; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Sabé A; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Martín L; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Segura-Bayona S; The Francis Crick Institute, London, UK.; Verde G; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Aiese Cigliano R; Sequentia Biotech SL, Barcelona, Spain.; Millanes-Romero A; Institute for Research in Biomedicine (IRB Barcelona) and Barcelona Institute of Science and Technology, Spain.; Jerónimo C; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institut de Recherches Cliniques de Montréal, Canada.; Cebrià-Costa JP; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Simonetti S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Viaplana C; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Oliveira M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Peg V; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain.; Stracker TH; Radiation Oncology Branch, National Cancer Institute, Bethesda, MD, USA.; Arribas J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Canals F; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Villanueva J; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Di Croce L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; García de Herreros A; Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.; Tian TV; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Peiró S; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publisher: Published by Blackwell Pub. on behalf of the Federation of European Biochemical Societies Country of Publication: England NLM ID: 101229646 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-4658 (Electronic) Linking ISSN: 1742464X NLM ISO Abbreviation: FEBS J Subsets: MEDLINE
Academic Journal
Gris-Oliver A; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ibrahim YH; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Rivas MA; Department of Medicine, Weil Cornell Medicine, New York, NY, USA.; García-García C; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Sánchez-Guixé M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ruiz-Pace F; Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Viaplana C; Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Pérez-García JM; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Barcelona, Spain.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Madrid, Spain.; Llombart-Cussac A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA.; Grueso J; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Parés M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Guzmán M; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Rodríguez O; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Anton P; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Cozar P; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Calvo MT; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Bruna A; Preclinical Modelling of Paediatric Cancer Evolution Team, Institute of Cancer Research, Sutton, UK.; Arribas J; Growth Factors Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, Bellaterra, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Caldas C; Department of Oncology and Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre at Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Dienstmann R; Oncology Data Science (ODysSey Group), Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Nuciforo P; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Oliveira M; Department of Medical Oncology, Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Cortés J; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain. jacortes@vhio.net.; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA. jacortes@vhio.net.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Barcelona, Spain. jacortes@vhio.net.; Breast Cancer Program, Quironsalud Group, Institute of Oncology (IOB), Madrid, Spain. jacortes@vhio.net.; Breast Cancer GroupVall d'Hebron Institute of Oncology, Barcelona, Spain. jacortes@vhio.net.; Serra V; Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. vserra@vhio.net.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. vserra@vhio.net.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Viaplana, C.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어